Lulu returned from Portugal where she had organized a successful meeting in multiple roles including meeting organizer, session chair, and presenter. The 2024 NAD+ Meeting represents the latest in a biennial meeting series that has grown since 2009. It is the premier international conference focused on NAD biology.
In addition to amazing new science (2 Plenary Talks, 30 US and international speakers, and over 80 additional poster presentations) we also introduced some inaugural programming events in 2024:
A new career-development initiative “Mentoring As a Two-Way Street” conducted by Dr. Wendy Ingram of DragonFly.
New dedicated speaker sessions for current clinical trials, neurobiology, cancer, and late-breaking data.
A special Forum and call to action about the clinical potential of NAD+, professionally moderated by Dr. David Katz.
From Bench to Clinic: Reflecting our growing field, the breadth of this meeting encompassed a vast diversity of biological topics and diseases, as well as includes the entire NAD metabolome such as NAD+, NADH, NADP+, NADPH, NaADP, ADP-Ribose, cyclic ADPR, Methylated-Nam, and pyridone nucleotides. The meeting further hosts researchers who use approaches that scale from atomic structural analyses to human physiology.
Meeting Organizers (L to R):
Andreas H. Guse, Dr.rer.nat. Dr.med.habil. Director Dept. of Biochemistry and Molecular Cell Biology, Vice-Dean of Education and Students’ Affaires, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Xiaolu A. Cambronne, Ph.D. Assistant Professor Department of Molecular Biosciences, UT Austin.
Santina Bruzzone, Ph.D. Professor of Biochemistry, University of Genova, Italy.
Michael O. Hottiger, Ph.D. Professor of Biochemistry and Molecular Biology; Director Dept. of Molecular Mechanisms of Disease, University of Zurich, Switzerland.
Comments